We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+3.36%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$4.51B
AUM Growth
+$737M
Cap. Flow
+$736M
Cap. Flow %
16.32%
Top 10 Hldgs %
19.25%
Holding
501
New
284
Increased
70
Reduced
66
Closed
74

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$99.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$80.7M
3
JNJ icon
Johnson & Johnson
JNJ
+$77.7M
4
EA icon
Electronic Arts
EA
+$61.9M
5
DHR icon
Danaher
DHR
+$60.2M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$99.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$97.8M
3
MDT icon
Medtronic
MDT
+$68.7M
4
NXPI icon
NXP Semiconductors
NXPI
+$61.6M
5
LITE icon
Lumentum
LITE
+$58.9M

Sector Composition

Rank Sector Weight
1 Healthcare 47.83%
2 Technology 26.25%
3 Communication Services 6.68%
4 Consumer Discretionary 4.05%
5 Financials 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DYN icon
176
Dyne Therapeutics
DYN
$4.78B
$5.94M 0.13%
382,493
-108,493
-22% -$2.1M
CANO
177
DELISTED
Cano Health, Inc.
CANO
$5.93M 0.13%
4,478
-3,810
-46% -$5.39M
LUNG icon
178
Pulmonx
LUNG
$87.4M
$5.86M 0.13%
128,092
+116
+0.1% +$6.65K
KALV
179
DELISTED
KalVista Pharmaceuticals
KALV
$5.76M 0.13%
+224,059
New +$5.89M
TNGX icon
180
Tango Therapeutics
TNGX
$4.55B
$5.6M 0.12%
503,397
– –
KRON
181
DELISTED
Kronos Bio
KRON
$5.5M 0.12%
188,085
-33,402
-15% -$978K
JD icon
182
JD.com
JD
$44.2B
$5.45M 0.12%
+64,640
New +$5.93M
BLSA
183
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$5.42M 0.12%
512,616
– –
IFF icon
184
International Flavors & Fragrances
IFF
$20.5B
$5.42M 0.12%
+38,784
New +$5.02M
CERE
185
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$5.39M 0.12%
+392,910
New +$5.75M
MRTX
186
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$5.33M 0.12%
+31,103
New +$6.16M
AVT icon
187
Avnet
AVT
$7.55B
$5.26M 0.12%
126,700
-206,571
-62% -$7.99M
FRPT icon
188
Freshpet
FRPT
$3.01B
$5.19M 0.12%
+32,677
New +$4.93M
EL icon
189
Estee Lauder
EL
$30.6B
$5.14M 0.11%
17,679
-38,210
-68% -$10.5M
ALGN icon
190
Align Technology
ALGN
$12.3B
$5.11M 0.11%
+9,442
New +$5.22M
LEAP
191
DELISTED
Ribbit LEAP, Ltd.
LEAP
$5.1M 0.11%
463,522
-593,878
-56% -$8M
REVHU
192
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Units
REVHU
$5.03M 0.11%
+500,000
New +$5.02M
CVIIU
193
DELISTED
Churchill Capital Corp VII Units
CVIIU
$4.99M 0.11%
+500,000
New +$5.16M
IPAR icon
194
Interparfums
IPAR
$4.03B
$4.98M 0.11%
70,193
-3,080
-4% -$209K
ARW icon
195
Arrow Electronics
ARW
$11.5B
$4.98M 0.11%
44,901
-404,655
-90% -$42.1M
AAQC.U
196
DELISTED
Accelerate Acquisition Corp Units
AAQC.U
$4.96M 0.11%
+500,000
New +$4.93M
STRO icon
197
Sutro Biopharma
STRO
$424M
$4.92M 0.11%
21,597
+3,379
+19% +$802K
BIIB icon
198
Biogen
BIIB
$29.9B
$4.89M 0.11%
+17,476
New +$4.71M
ANZUU
199
DELISTED
Anzu Special Acquisition Corp I Units
ANZUU
$4.74M 0.11%
+475,000
New +$4.75M
EAR
200
DELISTED
Eargo, Inc. Common Stock
EAR
$4.72M 0.1%
+4,727
New +$5.4M
6 7
8
9 10

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM

Woodline Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Woodline Partners held 501 positions worth $4.51B, up 20% from $3.77B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Woodline Partners deployed $736M of net new capital in Q1 2021, opening 284 new positions and adding to 70 existing holdings. Its largest new stake was Gilead Sciences: 1,541,893 shares worth $99.7M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 43% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Amgen, an estimated $99.3M trimmed.

  • Woodline Partners's largest Q1 2021 buy was Gilead Sciences: 1,541,893 shares worth $99.7M.
  • Woodline Partners added most to Regeneron Pharmaceuticals in Q1 2021, an estimated $80.7M increase.
  • Woodline Partners's biggest Q1 2021 reduction was Amgen, cutting an estimated $99.3M.
  • Woodline Partners fully exited Alphabet (Google) Class A in Q1 2021, selling an estimated $97.8M.
  • Woodline Partners's ten largest holdings make up 19% of its $4.51B portfolio in Q1 2021.
  • Woodline Partners opened 284 new positions and closed 74 in Q1 2021.
  • Woodline Partners's portfolio value rose 20% quarter-over-quarter to $4.51B.

Based on Woodline Partners's 13F filing for Q1 2021, filed 17 May 2021.